O
Olga Barbarash
Researcher at Kemerovo State University
Publications - 453
Citations - 6545
Olga Barbarash is an academic researcher from Kemerovo State University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 346 publications receiving 5575 citations. Previous affiliations of Olga Barbarash include Russian Academy of Sciences & Altai State Medical University.
Papers
More filters
Journal ArticleDOI
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
Gary R. Hudes,Michael A. Carducci,Piotr Tomczak,Janice P. Dutcher,Robert A. Figlin,Anil Kapoor,Elzbieta Staroslawska,Jeffrey A. Sosman,David F. McDermott,Istvan Bodrogi,Zoran Kovacevic,Vladimir Lesovoy,Ingo G.H. Schmidt-Wolf,Olga Barbarash,Erhan Gokmen,Timothy O'Toole,Stephanie Lustgarten,Laurence Moore,Robert J. Motzer +18 more
TL;DR: As compared with interferon alfa, temsirolimus improved overall survival among patients with metastatic renal-cell carcinoma and a poor prognosis.
Journal ArticleDOI
Fourth universal definition of myocardial infarction. focus on the type 2 myocardial infarction
Journal ArticleDOI
The Influence of Low and Moderate Carotid Stenosis on Neurophysiologic Status of Patients Undergoing on-pump Coronary Artery Bypass Grafting
TL;DR: It was established that the group ICA stenosis had a negative dynamics of neurophysiologic status 6 months follow-up after CABG compared with patients without stenosis.
Journal ArticleDOI
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Hossein Ardeschir Ghofrani,Hossein Ardeschir Ghofrani,Gérald Simonneau,Gérald Simonneau,Andrea Maria D'Armini,Peter F. Fedullo,Luke Howard,Luke Howard,Xavier Jaïs,Xavier Jaïs,David P. Jenkins,Zhi-Cheng Jing,Michael M. Madani,Nicolas Martin,Eckhard Mayer,Kelly Papadakis,Dominik Richard,Nick H. Kim,Irene Lang,Christian M. Kähler,Marion Delcroix,Zoheir Bshouty,Pablo Sepulveda Varela,Yuanhua Yang,Jin-Ming Liu,Gang-Cheng Zhang,Nuofu Zhang,Yuhong Mi,Xian-Yang Zhu,Pavel Jansa,Grégoire Prévot,Hélène Bouvaist,Olivier Sanchez,Friedrich Grimminger,Matthias Held,Heinrike Wilkens,Stephan Rosenkranz,Ekkehard Grünig,Kristóf Karlócai,András Temesvári,Istvan Edes,Sigita Aidietienė,Skaidrius Miliauskas,Tomas Rene Pulido Zamudio,Carlos Jerjes Sanchez,Anton Vonk Noordegraaf,Jerzy Lewczuk,Piotr Podolec,Jarosław Kasprzak,Tatiana Mularek-Kubzdela,Ryszard Grzywna,Keertan Dheda,Olga Moiseeva,Alexander Chernyavskiy,Vladimir M. Shipulin,Olga Barbarash,Tamila Vitalievna Martynyuk,Hyung Kwan Kim,Jun Bean Park,Jae Seung Lee,Rudolf Speich,Silvia Ulrich,John-David Aubert,Arintaya Phrommintikul,Nattapong Jaimchariyatam,Suree Sompradeekul,Zeynep Pinar Onen,Gulfer Okumus,Lyubomyr Solovey,Volodymyr Gavrysyuk,Luke S. Howard,Joanna Pepke-Zaba,Robin Condliffe,John McConnell,Kim M. Kerr,Lan Hieu Nguyen,Nguyen Vinh Pham +76 more
TL;DR: In MERIT-1, macitentan significantly improved PVR in patients with inoperable CTEPH and was well tolerated, and resting PVR at week 16, expressed as percentage of PVR measured at baseline.
Journal ArticleDOI
Leptin resistance: underlying mechanisms and diagnosis
TL;DR: This review of existing data on the methods used to diagnose leptin resistance encompasses a complex pathophysiological phenomenon with a number of potential research lines.